Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds

Advertisement

Zydus, Lupin get USFDA nod for generic drugs

New Delhi, February 16 Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain...

PTI

Updated At : 12:32 PM Feb 17, 2024 IST

featured-img

Advertisement

New Delhi, February 16

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain heart condition.

The US Food and Drug Administration (USFDA) has also given approval to Pharma major Lupin Ltd to market its generic ‘Minzoya’ tablets used to prevent pregnancy.

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Copyright © The Tribune Trust, 2024

Designed and developed by : SORTD